Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Blood-Borne Autologous Angiogenic Cells Precursors Therapy in Patients With Critical Limb Ischemia

NCT00523731 is registered in ClinicalTrials.gov with TheraVitae Ltd. as lead sponsor.

NCT NCT00523731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00523731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Blood-Borne Autologous Angiogenic Cells Precursors Therapy in Patients With Critical Limb Ischemia
Lead sponsor
TheraVitae Ltd.
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2006
Completion date
March 31, 2007
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia, peripheral arterial disease